Name
Alnylam Pharmaceuticals
What We Do
About Alnylam Pharmaceuticals Since its founding, Alnylam has led the translation of RNA interference (RNAi) into a new class of approved and investigational medicines for rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Alnylam is headquartered in Cambridge, MA. For more information, visit https://www.alnylam.com.
Website
Categories (6)
Pharmaceutical, Pharmaceutical